Literature DB >> 34222652

An integrated hypothesis for miR-126 in vascular disease.

Bo Yu1, Yinghua Jiang2, Xiaoying Wang2, Shusheng Wang1,3.   

Abstract

microRNA miR-126 was among the early discovered miRNAs that are expressed specifically in the vasculature and have critical functions in vascular development. Recent studies have started to unveil potentially important function of miR-126 in vascular diseases, including atherosclerosis, coronary artery disease, stroke and diabetic vasculopathy. The action of miR-126 reflects its function in angiogenesis and inflammation. The expression of miR-126 is downregulated in a variety of vascular diseases, and miR-126 overexpression appears to beneficial for most vascular disease models. In the minireview, we summarize the historic and current research regarding miR-126 function and mechanisms in the vascular system, its link to long noncoding RNAs (lncRNA), as well as the potential of miR-126-based therapeutics for vascular diseases. To explain the seemingly conflicting function of miR-126 from different studies, an integrated hypothesis is proposed that miR-126 has strand- and cell type-specific functions in angiogenesis and inflammation, making it beneficial in many different vascular disease models.

Entities:  

Year:  2020        PMID: 34222652      PMCID: PMC8247566          DOI: 10.18103/mra.v8i5.2133

Source DB:  PubMed          Journal:  Med Res Arch        ISSN: 2375-1916


  56 in total

1.  Circulating microRNAs in patients with coronary artery disease.

Authors:  Stephan Fichtlscherer; Salvatore De Rosa; Henrik Fox; Thomas Schwietz; Ariane Fischer; Christoph Liebetrau; Michael Weber; Christian W Hamm; Tino Röxe; Marga Müller-Ardogan; Angelika Bonauer; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circ Res       Date:  2010-07-01       Impact factor: 17.367

2.  Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy.

Authors:  Shruti Rawal; Pujika Emani Munasinghe; Amol Shindikar; Jono Paulin; Vicky Cameron; Patrick Manning; Michael J A Williams; Gregory T Jones; Richard Bunton; Ivor Galvin; Rajesh Katare
Journal:  Cardiovasc Res       Date:  2017-01-08       Impact factor: 10.787

Review 3.  MicroRNA-based therapeutics in central nervous system injuries.

Authors:  Ping Sun; Da Zhi Liu; Glen C Jickling; Frank R Sharp; Ke-Jie Yin
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-30       Impact factor: 6.200

4.  MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1.

Authors:  Andreas Schober; Maliheh Nazari-Jahantigh; Yuanyuan Wei; Kiril Bidzhekov; Felix Gremse; Jochen Grommes; Remco T A Megens; Kathrin Heyll; Heidi Noels; Michael Hristov; Shusheng Wang; Fabian Kiessling; Eric N Olson; Christian Weber
Journal:  Nat Med       Date:  2014-03-02       Impact factor: 53.440

5.  Expression and significance of MiR-126 and VEGF in proliferative diabetic retinopathy.

Authors:  R Liu; C-M Liu; L-L Cui; L Zhou; N Li; X-D Wei
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-08       Impact factor: 3.507

6.  miR-126 regulates angiogenic signaling and vascular integrity.

Authors:  Jason E Fish; Massimo M Santoro; Sarah U Morton; Sangho Yu; Ru-Fang Yeh; Joshua D Wythe; Kathryn N Ivey; Benoit G Bruneau; Didier Y R Stainier; Deepak Srivastava
Journal:  Dev Cell       Date:  2008-08       Impact factor: 12.270

7.  EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution.

Authors:  Maike Schmidt; Kim Paes; Ann De Mazière; Tanya Smyczek; Stacey Yang; Alane Gray; Dorothy French; Ian Kasman; Judith Klumperman; Dennis S Rice; Weilan Ye
Journal:  Development       Date:  2007-07-11       Impact factor: 6.868

8.  Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases.

Authors:  Yong Jiang; Hui-yan Wang; Yan Li; Su-hong Guo; Lei Zhang; Jian-hui Cai; Hong-mei Cao; Chun-yan Wang; Hao Wang; Lei Liu
Journal:  Sci Rep       Date:  2014-05-22       Impact factor: 4.379

9.  Endothelial progenitor cell-derived exosomes, loaded with miR-126, promoted deep vein thrombosis resolution and recanalization.

Authors:  Jiacheng Sun; Zhiwei Zhang; Teng Ma; Ziying Yang; Jinlong Zhang; Xuan Liu; Da Lu; Zhenya Shen; Junjie Yang; Qingyou Meng
Journal:  Stem Cell Res Ther       Date:  2018-08-23       Impact factor: 6.832

10.  Circulating microRNAs (miR-126, miR-197, and miR-223) are associated with chronic kidney disease among elderly survivors of the Great East Japan Earthquake.

Authors:  Ryosuke Fujii; Hiroya Yamada; Mirai Yamazaki; Eiji Munetsuna; Yoshitaka Ando; Koji Ohashi; Hiroaki Ishikawa; Haruki Shimoda; Kiyomi Sakata; Akira Ogawa; Seiichiro Kobayashi; Koji Suzuki
Journal:  BMC Nephrol       Date:  2019-12-21       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.